← Leaderboards
Adam Rocker
Gelsana Therapeutics, Inc.
$624,642
Attributed
$624,642
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $325K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$624,642 · 2
By mechanism
R43$624,642 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Hydrogels”
- Sihong Wang · University Of Chicago$2,348,944
- Hua Wang · University Of Illinois At Urbana-Champaign$2,229,562
- Amir Sheikhi · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$2,144,122
- Michael B Albro · Boston University (Charles River Campus)$2,133,303
- Gonzalo Munoz Taboada · Biodevek Inc$2,072,066
- Jonathan Robert Sukovich · University Of Michigan At Ann Arbor$1,999,023
Research focus
HydrogelsLicensingDiabetic Wound HealingHospitalizationInflammatoryIn VitroDiabetic MouseDiabetic UlcerForeign BodiesHealingInfectionInflammationInflammatory ResponseBolus InfusionAdsorptionDiabeticChargeChronicAmputationColoradoBandageFormulationImpaired Wound HealingLower Extremity
Grant awards (2)
Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation$324,992
R43 · FY2024 · DK · contact PI
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing$299,650
R43 · FY2023 · DK · contact PI